BCM
IONS icon

Brookstone Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Brookstone Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-38,035
Closed -$1.75M – 832
2022
Q3 		$1.75M Buy
38,035
+12,694
+50% +$535K 0.04% 305
2022
Q2 		$941K Buy
25,341
+2,970
+13% +$112K 0.02% 421
2022
Q1 		$886K Buy
22,371
+8,424
+60% +$276K 0.02% 439
2021
Q4 		$424K Buy
13,947
+2,550
+22% +$80.3K 0.01% 556
2021
Q3 		$382K Buy
+11,397
New +$429K 0.01% 553

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Brookstone Capital Management's IONS Position: Q4 2022 in Review

Brookstone Capital Management sold out of Ionis Pharmaceuticals (IONS) in Q4 2022, closing a stake of 38,035 shares — an estimated $1.75M sold.

Brookstone Capital Management first reported a position in IONS in Q3 2021 and held it in 5 quarters. The position peaked at $1.75M in Q3 2022. 338 funds tracked by Wall St. Rank hold IONS as of Q4 2022.

  • Brookstone Capital Management reported no remaining Ionis Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Brookstone Capital Management sold 38,035 Ionis Pharmaceuticals shares in Q4 2022, an estimated $1.75M.
  • Brookstone Capital Management first reported a position in Ionis Pharmaceuticals in Q3 2021 and held it in 5 quarters.
  • Brookstone Capital Management's Ionis Pharmaceuticals position peaked at $1.75M in Q3 2022.
  • 338 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2022.

Based on Brookstone Capital Management's 13F filing for Q4 2022, filed 9 Jan 2023.